- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Fujimori unveils enzymatic process in bacteria that leads to antibiotic resistance
By UCSF School of Pharmacy Editorial Staff / Thu Apr 15, 2010
Research results published from the UCSF research laboratory of Danica Galonić Fujimori, PhD, have revealed a radical approach employed by bacteria to alter their ribosomes and thereby evade antibiotics. These findings could ultimately lead to the development of ways to block this enzymatic transformation. Fujimori, who is a joint faculty member in the UCSF Schools of Pharmacy and Medicine, reported on results at the March 21–25, 2010, meeting of the American Chemical Society held in San Francisco, California. A highlight of her presentation appeared in Chemical and Engineering News, March 24, 2010.
More
Tags
Category:
Sites:
School of Pharmacy, Department of Pharmaceutical Chemistry, PharmD Degree Program, QBC, CCB, Biophysics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.